146 related articles for article (PubMed ID: 21569199)
21. Prognostic utility of apoptosis index, Ki-67 and survivin expression in dogs with nasal carcinoma treated with orthovoltage radiation therapy.
Fu DR; Kato D; Watabe A; Endo Y; Kadosawa T
J Vet Med Sci; 2014 Nov; 76(11):1505-12. PubMed ID: 25452259
[TBL] [Abstract][Full Text] [Related]
22. Prospective evaluation of a 5 × 4 Gy prescription for palliation of canine nasal tumors.
Tan-Coleman B; Lyons J; Lewis C; Rosenberg M; Ruiz A
Vet Radiol Ultrasound; 2013; 54(1):89-92. PubMed ID: 23002718
[TBL] [Abstract][Full Text] [Related]
23. Use of an image-guided robotic radiosurgery system for the treatment of canine nonlymphomatous nasal tumors.
Glasser SA; Charney S; Dervisis NG; Witten MR; Ettinger S; Berg J; Joseph R
J Am Anim Hosp Assoc; 2014; 50(2):96-104. PubMed ID: 24446402
[TBL] [Abstract][Full Text] [Related]
24. Retrospective review of 50 canine nasal tumours evaluated by low-field magnetic resonance imaging.
Avner A; Dobson JM; Sales JI; Herrtage ME
J Small Anim Pract; 2008 May; 49(5):233-9. PubMed ID: 18373540
[TBL] [Abstract][Full Text] [Related]
25. Radiological assessment of severity of canine nasal tumours and relationship with survival.
Morris JS; Dunn KJ; Dobson JM; White RA
J Small Anim Pract; 1996 Jan; 37(1):1-6. PubMed ID: 8642793
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of midline shift of the olfactory or frontal lobes of the brain in canine nasal carcinomas treated by palliative radiotherapy: a pilot study.
Wada Y; Noguchi S; Sasaki H; Taketomi A; Hamakawa M; Shimamura S; Shimada T
J Vet Med Sci; 2018 Nov; 80(11):1724-1727. PubMed ID: 30305466
[TBL] [Abstract][Full Text] [Related]
27. Combination of radiation therapy and firocoxib for the treatment of canine nasal carcinoma.
Cancedda S; Sabattini S; Bettini G; Leone VF; Laganga P; Rossi F; Terragni R; Gnudi G; Vignoli M
Vet Radiol Ultrasound; 2015; 56(3):335-43. PubMed ID: 25703137
[TBL] [Abstract][Full Text] [Related]
28. [Hypofractionated radiation therapy for the treatment of malignant melanoma and squamous cell carcinoma in dogs and cats].
Kinzel S; Hein S; Stopinski T; Koch J; Buecker A; Treusacher HP; Schmachtenberg A; Jansen T; Eble M; Küpper W
Berl Munch Tierarztl Wochenschr; 2003; 116(3-4):134-8. PubMed ID: 12680280
[TBL] [Abstract][Full Text] [Related]
29. COX-2 expression in canine anal sac adenocarcinomas and in non-neoplastic canine anal sacs.
Knudsen CS; Williams A; Brearley MJ; Demetriou JL
Vet J; 2013 Sep; 197(3):782-7. PubMed ID: 23778258
[TBL] [Abstract][Full Text] [Related]
30. Long-term outcome of 56 dogs with nasal tumours treated with four doses of radiation at intervals of seven days.
Mellanby RJ; Stevenson RK; Herrtage ME; White RA; Dobson JM
Vet Rec; 2002 Aug; 151(9):253-7. PubMed ID: 12233825
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of outcomes and radiation complications in 65 cats with nasal tumours treated with palliative hypofractionated radiotherapy.
Fujiwara-Igarashi A; Fujimori T; Oka M; Nishimura Y; Hamamoto Y; Kazato Y; Sawada H; Yayoshi N; Hasegawa D; Fujita M
Vet J; 2014 Dec; 202(3):455-61. PubMed ID: 25312719
[TBL] [Abstract][Full Text] [Related]
32. Prognostic status of p53 gene mutation in canine mammary carcinoma.
Wakui S; Muto T; Yokoo K; Yokoo R; Takahashi H; Masaoka T; Hano H; Furusato M
Anticancer Res; 2001; 21(1B):611-6. PubMed ID: 11299814
[TBL] [Abstract][Full Text] [Related]
33. Reirradiation of canine nasal carcinomas treated with coarsely fractionated radiation protocols: 37 cases.
Gieger T; Siegel S; Rosen K; Jackson D; Ware K; Kiselow M; Shiomitsu K
J Am Anim Hosp Assoc; 2013; 49(5):318-24. PubMed ID: 23861260
[TBL] [Abstract][Full Text] [Related]
34. Late presentation of canine nasal tumours in a UK referral hospital and treatment outcomes.
Mason SL; Maddox TW; Lillis SM; Blackwood L
J Small Anim Pract; 2013 Jul; 54(7):347-53. PubMed ID: 23718867
[TBL] [Abstract][Full Text] [Related]
35. Prognostic factors and survival after radiotherapy for intranasal neoplasms in dogs: 70 cases (1974-1985).
Evans SM; Goldschmidt M; McKee LJ; Harvey CE
J Am Vet Med Assoc; 1989 May; 194(10):1460-3. PubMed ID: 2722643
[TBL] [Abstract][Full Text] [Related]
36. Clinical significance of cyclooxygenase-2 expression in extranodal natural killer (NK)/T-cell lymphoma, nasal type.
Shim SJ; Yang WI; Shin E; Koom WS; Kim YB; Cho JH; Suh CO; Kim JH; Kim GE
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):31-8. PubMed ID: 17049184
[TBL] [Abstract][Full Text] [Related]
37. An immunohistochemical study of the inflammatory infiltrate associated with nasal carcinoma in dogs and cats.
Vanherberghen M; Day MJ; Delvaux F; Gabriel A; Clercx C; Peeters D
J Comp Pathol; 2009 Jul; 141(1):17-26. PubMed ID: 19362315
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of tumor volume reduction of nasal carcinomas versus sarcomas in dogs treated with definitive fractionated megavoltage radiation: 15 cases (2010-2016).
Morgan MJ; Lurie DM; Villamil AJ
BMC Res Notes; 2018 Jan; 11(1):70. PubMed ID: 29361976
[TBL] [Abstract][Full Text] [Related]
39. Differential cyclooxygenase-2 expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix.
Kim YB; Kim GE; Pyo HR; Cho NH; Keum KC; Lee CG; Seong J; Suh CO; Park TK
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):822-9. PubMed ID: 15465199
[TBL] [Abstract][Full Text] [Related]
40. Retrospective study of canine nasal tumor treated with hypofractionated radiotherapy.
Maruo T; Shida T; Fukuyama Y; Hosaka S; Noda M; Ito T; Sugiyama H; Ishikawa T; Madarame H
J Vet Med Sci; 2011 Feb; 73(2):193-7. PubMed ID: 20938105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
